Smad proteins exist as monomers in vivo and undergo homo- and hetero-oligomerization upon activation by serine/threonine kinase receptors

EMBO Journal

Volumn 17, Issue 14, 1998, Pages 4056-4065

  Kawabata, Masahiro ^a   Inoue, Hirofumi ^a   Hanyu, Aki ^a   Imamura, Takeshi ^a   Miyazono, Kohei ^a  

^a CANCER INSTITUTE   (Japan)

Author keywords

Oligomer; Serine; Signal transduction; Smad; TGF ; Threonine kinase receptor

Indexed keywords

OLIGOMER; PROTEIN SERINE THREONINE KINASE; TRANSFORMING GROWTH FACTOR BETA;

ARTICLE; GEL CHROMATOGRAPHY; OLIGOMERIZATION; PRIORITY JOURNAL; PROTEIN FAMILY; PROTEIN INDUCTION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION;

ACTIVIN RECEPTORS, TYPE I; ANIMALS; BINDING, COMPETITIVE; CARCINOMA; CHROMATOGRAPHY, GEL; COLONIC NEOPLASMS; COS CELLS; CROSS-LINKING REAGENTS; DNA; DNA-BINDING PROTEINS; MOLECULAR WEIGHT; PHOSPHORYLATION; PROTEIN CONFORMATION; PROTEIN-SERINE-THREONINE KINASES; RECEPTORS, TRANSFORMING GROWTH FACTOR BETA; SIGNAL TRANSDUCTION; SMAD2 PROTEIN; SMAD3 PROTEIN; SUCCINIMIDES; TRANS-ACTIVATORS; TRANSFECTION; TUMOR CELLS, CULTURED;

EID: 0032528041     PISSN: 02614189     EISSN: None     Source Type: Journal    
DOI: 10.1093/emboj/17.14.4056     Document Type: Article

References (51)

1. 467 is required for Smad2-Smad4 complex formation and signaling. J. Biol. Chem., 272, 27678-27685.
2. Baker,J.C. and Harland,R.M. (1996) A novel mesoderm inducer, Madr2, functions in the activin signal transduction pathway. Genes Dev., 10, 1880-1889.
3. Candia,A.F., Watabe,T., Hawley,S.H.B., Onichtchouk,D., Zhang,Y., Derynck,R., Niehrs,C. and Cho,K.W.Y. (1997) Cellular interpretation of multiple TGF-β signals: intracellular antagonism between activin/ BVg1 and BMP-2/4 signaling mediated by Smads. Development, 124, 4467-4480.
4. Cárcamo,J., Weis,F.M.B., Ventura,F., Wieser,R., Wrana,J.L., Attisano,L. and Massagué,J. (1994) Type I receptors specify growth-inhibitory and transcriptional responses to transforming growth factor β and activin. Mol. Cell. Biol., 14, 3810-3821.
5. Cárcamo,J., Zentella,A. and Massagué,J. (1995) Disruption of transforming growth factor β signaling by a mutation that prevents transphosphorylation within the receptor complex. Mol. Cell. Biol., 15, 1573-1581.
6. Chen,R.-H. and Derynck,R. (1994) Homomeric interactions between type II transforming growth factor-β receptors. J. Biol. Chem., 269, 22868-22874.
7. Chen,X., Rubock,M.J. and Whitman,M. (1996) A transcriptional partner for MAD proteins in TGF-β signalling, Nature, 383, 691-696.
8. Chen,X., Weisberg,E., Fridmacher,V., Watanabe,M., Naco,G. and Whitman,M. (1997) Smad4 and FAST-1 in the assembly of activin-responsive factor. Nature, 389, 85-89.
9. Chen,Y., Bhushan,A. and Vale,W. (1997) Smad8 mediates the signaling of the receptor serine kinase. Proc. Natl Acad. Sci USA, 94, 12938-12943.
10. Datto,M.B., Yu,Y. and Wang,X.-F. (1995) Functional analysis of the transforming growth factor β responsive elements in the WAF1/Cip1/ p21 promoter. J. Biol. Chem., 270, 28623-28628.
11. Derynck,R. and Feng,X.-H. (1997) TGF-β receptor signaling. Biochim. Biophys. Acta, 1333, F105-F150.
12. Feng,X.-H. and Derynck,R. (1997) A kinase subdomain of transforming growth factor-β (TGF-β) type I receptor determines the TGF-β intracellular signaling specificity. EMBO J., 16, 3912-3923.
13. Gilboa,L., Wells,R.G., Lodish,H.F. and Henis,Y.I. (1998) Oligomeric structure of type I and type II transforming growth factor β receptors; Homodimers form in the ER and persist at the plasma membrane. J. Cell Biol., 140, 767-777.
14. Goldman,L.A., Cutrone,E.C, Kotenko,S.V., Krause,C.D. and Langer,J.A. (1996) Modifications of vectors pEF-BOS, pcDNA1 and pcDNA3 result in improved convenience and expression. Biotechniques, 21, 1013-1015.
15. Goyette,M.C., Cho,K., Fasching,C.L., Levy,D.B., Kinzler,K.W., Paraskeva,C., Vogelstein,B. and Stanbridge,E.J. (1992) Progression of colorectal cancer is associated with multiple tumor suppressor gene defects but inhibition of tumorigenicity is accomplished by correction of any single defect via chromosome transfer. Mol. Cell. Biol. 12, 1387-1395.
16. Graff,J.M., Bansal,A. and Melton,DA (1996) Xenopus Mad proteins transduce distinct subsets of signals for the TGFβ superfamily. Cell, 85, 479-487.
17. Hahn,S.A. et al. (1996) DPC4, a candidate tumor suppressor gene at human chromosome 18q21.1. Science, 271, 350-353.
18. Hata,A., Lo,R.S., Wotton,D., Lagna,G. and Massagué,J. (1997) Mutations increasing autoinhibition inactivate tumour suppressors Smad2 and Smad4. Nature, 388, 82-87.
19. Hata,A., Lagna,G., Massagué,J. and Hemmati-Brivanlou,A. (1998) Smad6 inhibits BMP/Smad1 signaling by specifically competing with the Smad4 tumor suppressor. Genes Dev., 12, 186-197.
20. Hayashi,H. et al. (1997) The MAD-related protein Smad7 associates with the TGFβ receptor and functions as an antagonist of TGFβ signaling. Cell. 89, 1165-1173.
21. Heldin,C,-H., Miyazono,K. and ten Dijke,P. (1997) TGF-β signalling from cell membrane to nucleus through SMAD proteins. Nature, 390, 465-471.
22. Henis,Y.I., Moustakas,A., Lin,H.Y. and Lodish,H.F. (1994) The types II and III transforming growth factor-β receptors form homo-oligomers. J. Cell Biol., 126, 139-154.
23. Hoodless,P.A., Haerry,T., Abdollah,S., Stapleton,M., O'Connor,M.B., Attisano,L. and Wrana,J.L. (1996) MADR1, a MAD-related protein that functions in BMP2 signaling pathways. Cell, 85, 489-500.
24. Imamura,T., Takase,M., Nishihara,A., Oeda,E., Hanai,J.-i., Kawabata,M. and Miyazono,K. (1997) Smad6 inhibits signalling by the TGF-β superfamily. Nature, 389, 622-626.
25. Inoue,H. et al. (1998) Interplay of signal mediators of Dpp: molecular characterization of Mothers against dpp, Medea, and Daughters against dpp. Mol. Biol. Cell, in press.
26. Kim,J., Johnson,K., Chen,H.J., Carroll,S. and Laughon,A (1997) Drosophila Mad binds to DNA and directly mediates activation of vestigial by Decapentaplegic. Nature, 388, 304-308.
27. Lagna,G., Hata,A., Hemmati-Brivanlou,A. and Massagué,J. (1996) Partnership between DPC4 and SMAD proteins in TGF-β signalling pathways. Nature, 383, 832-836.
28. Liu,F., Hata,A., Baker,J.C., Doody,J,. Cárcamo,J., Harland,R.M. and Massagué,J. (1996) A human Mad protein acting as a BMP-regulated transcriptional activator. Nature, 381, 620-623.
29. Liu,F., Pouponnot,C. and Massagué,J. (1997) Dual role of the Smad4/ DPC4 tumor suppressor in TGF-β-inducible transcriptional complexes. Genes Dev., 11, 3157-3167.
30. Liu,X., Sun,Y, Constantinescu,S.N., Karam,E., Weinberg,R.A, and Lodish,H.F. (1997) Transforming growth factor β-induced phosphorylation of Smad3 is required for growth inhibition and transcriptional induction in epithelial cells. Proc. Natl Acad. Sci. USA, 94, 10669-10674.
31. Macías-Silva,M., Abdollah,S., Hoodless,PA., Pirone,R., Attisano,L. and Wrana,J.L. (1996) MADR2 is a substrate of the TGFβ receptor and its phosphorylation is required for nuclear accumulation and signaling. Cell, 87, 1215-1224.
32. Massagué,J., Hata,A. and Liu,F. (1997) TGF-β signalling through the Smad pathway. Trends Cell Biol. 7, 187-192.
33. Meersseman,G. et al. (1997) The C-terminal domain of Mad-like signal transducers is sufficient for biological activity in the Xenopus embryo and transcriptional activation. Mech. Devel., 61, 127-140.
34. Nakao,A. et al. (1997a) Identification of Smad7, a TGFβ-inducible antagonist of TGF-β signalling. Nature, 389, 631-635.
35. Nakao,A. et al. (1997b) TGF-β receptor-mediated signalling through Smad2, Smad3 and Smad4, EMBO J., 16, 5353-5362.
36. Oeda,E., Oka,Y., Miyazono,K. and Kawabata,M. (1998) Interaction of Drosophila inhibitors of apontosis with Thick veins, a type I serine/ threonine kinase receptor for Decapentaplegic. J. Biol. Chem., 273, 9353-9356.
37. Riggins,G.J. et al. (1996) Mad-related genes in the human. Nature Genet., 13, 347-349.
38. Savage,C., Das,P., Finelli,A.L., Townsend,S.R., Sun,C.-Y., Baird,S.E. and Padgett,R.W. (1996) Caenorhabditis elegans genes sma-2, sma-3, and sma-4 define a conserved family of transforming growth factor β pathway components. Proc. Natl Acad. Sci. USA, 93, 790-794.
39. Sekelsky,J.J., Newfeld,S.J., Raftery,L.A., Chartoff,E.H. and Gelbart,W.M. (1995) Genetic characterization and cloning of mothers against dpp, a gene required for decapentaplegic function in Drosophila melanogaster. Genetics, 139, 1347-1358.
40. Shi,Y., Hata,A., Lo,R.S., Massagué,J. and Pavletich,N.P. (1997) A structural basis for mutational inactivation of the tumour suppressor Smad4. Nature, 388, 87-93.
41. 467 in the C terminus of Smad2 mediates interaction with Smad4 and is required for transforming growth factor-β signaling. J. Biol. Chem., 272, 28107-28115.
42. Topper,J.N. et al. (1997) Vascular MADs: two novel MAD-related genes selectively inducible by flow in human vascular endothelium. Proc. Natl Acad. Sci. USA, 94, 9314-9319.
43. Watanabe,T.K., Suzuki,M., Omori,Y., Hishigaki,H., Horie,M., Kanemoto,N., Fujiwara,T., Nakamura,Y. and Takuhashi,E. (1997) Cloning and characterization of a novel member of the human Mad gene family (MADH6). Genomics, 42, 446-451.
44. Weis-Garcia,F. and Massagué,J. (1996) Complementation between kinase-defective and activation-defective TGF-β receptors reveals a novel form of receptor cooperativity essential for signaling. EMBO J., 15, 276-289.
45. Wieser,R., Wrana,J.L. and Massagué,J. (1995) GS domain mutations that constitutively activate TβR-I, the downstream signaling component in the TGF-β receptor complex. EMBO J., 14, 2199-2208.
46. Wrana,J.L., Attisano,L., Wieser,R., Ventura,F. and MassaguéJ. (1994) Mechanism of activation of the TGF-β receptor. Nature, 370, 341-347.
47. Wu,R.-Y., Zhang,Y., Feng,X.-H. and Derynck,R. (1997) Heteromeric and homomeric interactions correlate with signaling activity and functional cooperativity of Smad3 and Smad4/DPC4. Mol. Cell. Biol., 17, 2521-2528.
48. Yamashita,H., ten Dijke,P., Franzén,P. Miyazono,K. and Heldin,C.-H. (1994) Formation of hetero-oligomeric complexes of type I and type II receptors for transforming growth factor-β. J. Biol. Chem., 269, 20172-20178.
49. Yingling,J.M., Datto,M.B., Wong,C., Frederick,J.P. Liberati,N.T. and Wang,X.-F. (1997) Tumor suppressor Smad4 is a transforming growth factor β-inducible DNA binding protein. Mol. Cell. Biol., 17, 7019-7028.
50. Zawel,L., Dai,J.L., Buckhaults,P., Zhou,S., Kinzler,K.W., Vogelstein,B. and Kern,S.E. (1998) Human Smad3 and Smad4 are sequence-specific transcription activators. Mol. Cell, 1, 611-617.
51. Zhang,Y., Feng,X.-H., Wu,R.-Y. and Derynck,R. (1996) Receptor-associated Mad homologues synergize as effectors of the TGF-β response. Nature, 383, 168-172.